艾迪药业：2025年年度业绩预告

Core Viewpoint - Eddie Pharmaceuticals announced an expected revenue of approximately 721.01 million yuan for the fiscal year 2025, representing a year-on-year increase of about 72.57% [1] Group 1 - The company anticipates a net profit attributable to the parent company in the range of -16 million to -24 million yuan for 2025 [1] - The projected loss margin is expected to decrease by approximately 88.67% to 83.00% year-on-year [1]